Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation

Payal R. Sheth, John L. Hays, Lisa Elferink, Stanley Watowich

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Ligand-induced dimerization of receptor tyrosine kinases (RTKs) modulates a system of linked biochemical reactions, sharply switching the RTK from a quiescent state to an active state that becomes phosphorylated and triggers intracellular signaling pathways. To improve our understanding of this molecular switch, we developed a quantitative model for hepatocyte growth factor receptor (c-MET) activation using parameters derived in large part from c-MET kinetic and thermodynamic experiments. Our model accurately produces the qualitative and quantitative dynamic features of c-MET phosphorylation observed in cells following ligand binding, including a rapid transient buildup of phosphorylated c-MET at high ligand concentrations. In addition, our model predicts a slow buildup of phosphorylated c-MET under conditions of reduced phosphatase activity and no extracellular agonist. Significantly, this predicted response is observed in cells treated with phosphatase inhibitors, further validating our model. Parameter sensitivity studies clearly show that synergistic oligomerization-dependent changes in c-MET kinetic, thermodynamic, and dephosphorylation properties result in the selective activation of the dimeric receptor, confirming that this model can be used to accurately evaluate the relative importance of linked biochemical reactions important for c-MET activation. Our model suggests that the functional differences observed between c-MET monomers and dimers may have incrementally evolved to optimize cell surface signaling responses.

Original languageEnglish (US)
Pages (from-to)4028-4038
Number of pages11
JournalBiochemistry
Volume47
Issue number13
DOIs
StatePublished - Apr 1 2008

Fingerprint

Proto-Oncogene Proteins c-met
Protein-Tyrosine Kinases
Chemical activation
Switches
Receptor Protein-Tyrosine Kinases
Ligands
Thermodynamics
Phosphoric Monoester Hydrolases
Dimerization
Phosphorylation
Oligomerization
Kinetics
Dimers
Monomers

ASJC Scopus subject areas

  • Biochemistry

Cite this

Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation. / Sheth, Payal R.; Hays, John L.; Elferink, Lisa; Watowich, Stanley.

In: Biochemistry, Vol. 47, No. 13, 01.04.2008, p. 4028-4038.

Research output: Contribution to journalArticle

@article{7a631280eb554cf0becf6c445959ceee,
title = "Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation",
abstract = "Ligand-induced dimerization of receptor tyrosine kinases (RTKs) modulates a system of linked biochemical reactions, sharply switching the RTK from a quiescent state to an active state that becomes phosphorylated and triggers intracellular signaling pathways. To improve our understanding of this molecular switch, we developed a quantitative model for hepatocyte growth factor receptor (c-MET) activation using parameters derived in large part from c-MET kinetic and thermodynamic experiments. Our model accurately produces the qualitative and quantitative dynamic features of c-MET phosphorylation observed in cells following ligand binding, including a rapid transient buildup of phosphorylated c-MET at high ligand concentrations. In addition, our model predicts a slow buildup of phosphorylated c-MET under conditions of reduced phosphatase activity and no extracellular agonist. Significantly, this predicted response is observed in cells treated with phosphatase inhibitors, further validating our model. Parameter sensitivity studies clearly show that synergistic oligomerization-dependent changes in c-MET kinetic, thermodynamic, and dephosphorylation properties result in the selective activation of the dimeric receptor, confirming that this model can be used to accurately evaluate the relative importance of linked biochemical reactions important for c-MET activation. Our model suggests that the functional differences observed between c-MET monomers and dimers may have incrementally evolved to optimize cell surface signaling responses.",
author = "Sheth, {Payal R.} and Hays, {John L.} and Lisa Elferink and Stanley Watowich",
year = "2008",
month = "4",
day = "1",
doi = "10.1021/bi701892f",
language = "English (US)",
volume = "47",
pages = "4028--4038",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "13",

}

TY - JOUR

T1 - Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation

AU - Sheth, Payal R.

AU - Hays, John L.

AU - Elferink, Lisa

AU - Watowich, Stanley

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Ligand-induced dimerization of receptor tyrosine kinases (RTKs) modulates a system of linked biochemical reactions, sharply switching the RTK from a quiescent state to an active state that becomes phosphorylated and triggers intracellular signaling pathways. To improve our understanding of this molecular switch, we developed a quantitative model for hepatocyte growth factor receptor (c-MET) activation using parameters derived in large part from c-MET kinetic and thermodynamic experiments. Our model accurately produces the qualitative and quantitative dynamic features of c-MET phosphorylation observed in cells following ligand binding, including a rapid transient buildup of phosphorylated c-MET at high ligand concentrations. In addition, our model predicts a slow buildup of phosphorylated c-MET under conditions of reduced phosphatase activity and no extracellular agonist. Significantly, this predicted response is observed in cells treated with phosphatase inhibitors, further validating our model. Parameter sensitivity studies clearly show that synergistic oligomerization-dependent changes in c-MET kinetic, thermodynamic, and dephosphorylation properties result in the selective activation of the dimeric receptor, confirming that this model can be used to accurately evaluate the relative importance of linked biochemical reactions important for c-MET activation. Our model suggests that the functional differences observed between c-MET monomers and dimers may have incrementally evolved to optimize cell surface signaling responses.

AB - Ligand-induced dimerization of receptor tyrosine kinases (RTKs) modulates a system of linked biochemical reactions, sharply switching the RTK from a quiescent state to an active state that becomes phosphorylated and triggers intracellular signaling pathways. To improve our understanding of this molecular switch, we developed a quantitative model for hepatocyte growth factor receptor (c-MET) activation using parameters derived in large part from c-MET kinetic and thermodynamic experiments. Our model accurately produces the qualitative and quantitative dynamic features of c-MET phosphorylation observed in cells following ligand binding, including a rapid transient buildup of phosphorylated c-MET at high ligand concentrations. In addition, our model predicts a slow buildup of phosphorylated c-MET under conditions of reduced phosphatase activity and no extracellular agonist. Significantly, this predicted response is observed in cells treated with phosphatase inhibitors, further validating our model. Parameter sensitivity studies clearly show that synergistic oligomerization-dependent changes in c-MET kinetic, thermodynamic, and dephosphorylation properties result in the selective activation of the dimeric receptor, confirming that this model can be used to accurately evaluate the relative importance of linked biochemical reactions important for c-MET activation. Our model suggests that the functional differences observed between c-MET monomers and dimers may have incrementally evolved to optimize cell surface signaling responses.

UR - http://www.scopus.com/inward/record.url?scp=41449090165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41449090165&partnerID=8YFLogxK

U2 - 10.1021/bi701892f

DO - 10.1021/bi701892f

M3 - Article

VL - 47

SP - 4028

EP - 4038

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 13

ER -